Blog - Page 3846 of 5585

TuesdayFeb 02, 2010 3:12 pm

Starpharma Holdings Limited (SPHRY.PK) is “One to Watch”

Starpharma Holdings Limited is a world leader in the development of dendrimer technology for pharmaceutical, life science, and other applications. Products based on SPL dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents through license arrangements with partners including Siemens and Merck KgA. Starpharma Holdings has two operating companies, Starpharma Pty Ltd in Melbourne, Australia and DNT, Inc. in the United States. In the pharmaceutical field, Starpharma is developing VivaGel® (SPL7013Gel) as a vaginal microbicide. Its design is to prevent the transmission of STIs, including HIV and genital herpes. Starpharma already has a…

TuesdayFeb 02, 2010 2:18 pm

Hecla Mining Co. (HL) Reports Record Production and Profit, Goes Debt Free While Maintaining $100 Million in Realized Profit

The metals markets are an interesting beast. Profits are up at one point and disappear the next. Some miners, however, have found their place. Solid veins, markets that seem to buy regularly and a cost structure that is well below market price. Generally, this might make that proverbial bell go off in one's head. In other circumstances it would offer up opportunity. If a company were to present itself, with these thoughts in mind, after being in operation for only a few years the bell might be valid. One that has been in operation, with these same thoughts for over…

TuesdayFeb 02, 2010 2:04 pm

Soligenix Inc. (SNGX.OB) Announces Publication Concerning Stability of Lead Vaccine, RiVax

Soligenix Inc is a late-stage biotechnology company developing products to treat the life-threatening side effects of cancer treatments and gastrointestinal diseases, as well as vaccines for certain bioterrorism agents. RiVax™ is the company’s proprietary vaccine developed to protect against exposure to ricin toxin, a plant toxin with the potential to be a bioterror threat. RiVax is the most advanced vaccine in the company's portfolio. The company today issued a press release pointing to the February 2010 edition of Vaccine, in which an article describing prelinical formulations of RiVax was published. RiVax is currently being evaluated in phase 1 human safety…

TuesdayFeb 02, 2010 2:02 pm

HST Global, Inc. (HSTC.OB) to Develop a Clinical Treatment Facility in Ecuador

HST Global, Inc., a leading integrated biotech, health and wellness concern, disclosed today that the Company will be developing a Clinical Treatment Facility in Ecuador, where prevailing conditions present lucrative opportunities for expanding its business model. By developing a network of Wellness Centers around the world focused on late-stage cancer treatments, immunotherapy, and other innovative solutions which the Company is constantly in the process of acquiring, HSTC focuses on treatments which have already undergone significant clinical testing to validate their efficaciousness for late-stage cancer patients. With readiness to utilize the sort of integrative and science-based cancer treatments that HSTC is…

TuesdayFeb 02, 2010 1:59 pm

Attunity Ltd. (ATTUF.OB) Software Selected by Turkey’s Social Security Institution

Attunity Ltd., the software developer specializing in event capture and real-time data integration that provides users with a customizable service-based framework to enable heightened business sector presence, announced today selection of its Attunity Stream software by the Turkish government's Social Security Institution (SGK). Attunity Stream is a log-based, change-data-capture (CDC) environment that allows for real-time detection of actionable events, and will be employed by the SGK to better serve the 60 million people under its umbrella. Part of an e-government initiative by SGK to develop a persistent data warehousing model with user driven business intelligence, the adoption of Attunity Stream…

TuesdayFeb 02, 2010 1:54 pm

GenSpera, Inc. (GNSZ.OB) Receives US Patent for Tumor Activated Prodrugs

Today, GenSpera, Inc. announced that the United States Patent and Trademark Office has issued the company’s patent application, entitled “Tumor Activated Prodrugs,” as US Patent 7,635,682. The patent covers the composition and potential uses of GenSpera’s G-115 second anti-cancer drug, which is currently in development. GenSpera, Inc. owns and controls all rights to G-115. The company anticipates a strategic partnership to maximize the drug’s value as it progresses through future clinical trials. G-115 can be selectively activated within prostate tumors by an enzyme, Prostate Specific Antigen (PSA), which is active only within prostate tissue and prostate cancer tumors. In preclinical…

TuesdayFeb 02, 2010 1:47 pm

Consorteum Holdings, Inc. (CSRH.OB) Led by an Exceptional Management Team

Consorteum Holdings Inc. is a leader in the payments and transactions industry worldwide. The company has taken special care in assembling a dedicated management and consulting team that has a diverse base of knowledge in the financial services, payment and transaction processing industry. Together the team has accumulated more than a century of high-level expertise. Director and CEO Craig Fielding has nearly 20 years of global business experience. He previously served in senior management roles in systems, sales and service for Xerox in North America. Mr. Fielding has also successfully developed consulting businesses, sat on the management team at Soft…

TuesdayFeb 02, 2010 1:42 pm

Halo Companies Inc. (GPAX.OB) Credit Solutions Subsidiary Adds HaloSafe ID to Suite of Identity Theft Protection Services

The Internet has opened a floodgate of innovative channels of identity theft. While online identity theft continues to rise, according to the Javelin Strategy & Research Institute, lost or stolen wallets still make up 42 percent of identity theft crimes. Regardless of how the crime is done, increased identity theft has created a growing market for credit repair and protection technologies. Halo Credit Solutions LLC is a full-service credit repair company and subsidiary of Halo Companies Inc. (GPAX.OB) focused on identity protection. The company today announced it will add HaloSafe ID to its portfolio of services, scheduled to roll-out in…

TuesdayFeb 02, 2010 12:02 pm

China Medicine Corp. (CHME.OB) Announces Closing of Financing, New Board Member

China Medicine Corp. is a developer, manufacturer and leading distributor of western pharmaceuticals, traditional Chinese medicines, nutriceuticals and other medical formulations in China. The company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The company announced today that it has closed the equity private placement contemplated in its stock subscription agreement dated December 31, 2009. It completed the placement with One Equity Partners, the global private equity investment arm of JPMorgan (NYSE: JPM). China Medicine sold 4 million of the company's…

TuesdayFeb 02, 2010 10:05 am

China Clean Energy (CCGY.OB) Announces Appointment of William Chen as Chief Financial Officer

China Clean Energy, Inc., a developer, manufacturer and distributor of biodiesel and specialty chemical products made from renewable resources in The People’s Republic of China, recently announced that the company has appointed William Chen as chief financial officer, effective February 1, 2010. Replacing Ms. Shannon Yan, who resigned on January 31, 2010 to pursue other career opportunities, Mr. Chen will leverage his expertise in the U.S. capital market and strengthen China Clean Energy’s profile as a U.S.-listed company. Prior to joining China Clean Energy as vice president of investor relations on December 3, 2009, Mr. Chen worked as a financial…

Site Search

Company Search